北京商报讯（记者 王寅浩 实习记者 宋雨盈）9月26日，同仁堂发布公告称，公司控股孙公司北京同仁 堂国药有限公司收到柬埔寨王国（以下简称"柬埔寨"）卫生部药品与食品司颁发的《传统药品注册许可 证》，准许将同仁堂国药的"同仁堂安宫牛黄丸"在柬埔寨出售，许可证有效期限至2028年9月11日止。 ...

Core Viewpoint - Hansen Pharmaceutical (002412) is currently in the process of scaling up the production technology for its new traditional Chinese medicine product, Cangrong Granules, which is in the pilot study phase [1] Group 1 - The company is actively engaged in product research and development [1] - Cangrong Granules is a new drug derived from traditional Chinese medicine [1] - The product is currently undergoing process pilot testing [1]

Core Viewpoint - Tong Ren Tang (600085.SH) has received a Traditional Medicine Registration License from the Ministry of Health of Cambodia, allowing its product "Tong Ren Tang An Gong Niu Huang Wan" to be sold in Cambodia [1] Group 1: Regulatory Approvals - The subsidiary Beijing Tong Ren Tang Guo Yao Co., Ltd. has obtained the Traditional Medicine Registration License, which follows the previously granted import license for the same product [1] - This license enables the distribution of Tong Ren Tang An Gong Niu Huang Wan in Cambodia, enhancing the product's market presence [1] Group 2: Market Expansion - The acquisition of the registration license is expected to enrich the distribution channels for key products of Tong Ren Tang Guo Yao, facilitating market expansion [1] - The impact of this license on the company's production operations and overall performance is not anticipated to be significant at this time [1]

Core Insights - Tong Ren Tang Technology (01666.HK) announced that its subsidiary, Tong Ren Tang Guo Yao, has received a Traditional Medicine Registration License from the Ministry of Health of the Kingdom of Cambodia, allowing the sale of "Tong Ren Tang An Gong Niu Huang Wan" in Cambodia [1][2] Group 1 - The drug "Tong Ren Tang An Gong Niu Huang Wan" is now authorized for sale in Cambodia, which will enhance the distribution channels for the company's key products and support market expansion [1][2] - The registration number for the license is CAM N0004IT-25, and it is valid until September 11, 2028 [2] - The acquisition of this license is not expected to have a significant impact on the company's production operations and performance in the short term [2] Group 2 - The sales of the drug may be influenced by changes in Cambodia's policy environment, exchange rate fluctuations, and market competition [2][3]

Core Viewpoint - Tong Ren Tang (600085.SH) has received a Traditional Medicine Registration License from the Ministry of Health of the Kingdom of Cambodia, allowing its subsidiary Beijing Tong Ren Tang Guo Yao Co., Ltd. to sell "Tong Ren Tang An Gong Niu Huang Wan" in Cambodia [1] Group 1 - The approval from the Cambodian authorities marks a significant step for the company in expanding its international market presence [1] - The product "Tong Ren Tang An Gong Niu Huang Wan" is a traditional Chinese medicine, indicating the company's commitment to promoting traditional medicine abroad [1]

2025 年 9 月 27 日，北京同仁堂股份有限公司公告，其控股孙公司北京同仁堂国药有限公司收到柬埔寨 卫生部药品与食品司颁发的《传统药品注册许可证》，准许"同仁堂安宫牛黄丸"在柬出售。许可证编号 为 CAMN00041T - 25，有效期至 2028 年。此前该药品已获柬进口许可证，此次获注册许可有助于丰富 分销渠道、拓展市场，但暂不会对公司生产经营和业绩产生重大影响。同时，药品销售受政策、汇率、 竞争等因素影响，提醒投资者注意风险。 ...

同仁堂9月26日公告，公司控股孙公司同仁堂国药收到柬埔寨卫生部药品与食品司颁发的《传统药品注 册许可证》，准许将同仁堂国药的"同仁堂安宫牛黄丸"在柬埔寨出售。药品销售受多种因素影响，投资 者需注意投资风险。 ...

同仁堂（600085）(600085.SH)公告，公司控股孙公司北京同仁堂国药有限公司(同仁堂国药)收到柬埔寨 王国(柬埔寨)卫生部药品与食品司颁发的《传统药品注册许可证》，准许将同仁堂国药的"同仁堂安宫 牛黄丸"在柬埔寨出售。 ...

智通财经APP讯，同仁堂国药(03613)发布公告，公司于近日收到柬埔寨王国(柬埔寨)卫生部药品与食品 司颁发的《传统药品注册许可证》("许可证")，准许将公司的"同仁堂安宫牛黄丸"在柬埔寨出售。 "同仁堂安宫牛黄丸"应遵照持证的中医师的指导下使用。另外，早前柬埔寨卫生部亦已颁发"同仁堂安 宫牛黄丸"进口许可证。 本次公司取得柬埔寨卫生部药品与食品司签发的许可证后，公司的"同仁堂安宫牛黄丸"可在柬埔寨出 售，有助于丰富公司重点产品的分销渠道，有利于公司的市场拓展。上述许可证的取得暂不会对公司生 产经营和业绩产生重大影响。药品销售容易受到柬埔寨政策环境变化、汇率波动、市场竞争等因素的影 响。 ...

格隆汇9月26日丨同仁堂国药(03613.HK)发布公告，公司于近日收到柬埔寨卫生部药品与食品司颁发的 《传统药品注册许可证》，准许将公司的"同仁堂安宫牛黄丸"在柬埔寨出售。本次本公司取得柬埔寨卫 生部药品与食品司签发的许可证后，公司的"同仁堂安宫牛黄丸"可在柬埔寨出售，有助于丰富公司重点 产品的分销渠道，有利于公司的市场拓展。 ...